For the Inventor, By the Inventor

Enter assignee name

Abbotsford, Australia

Starpharma Pty Limited

USPTO Granted Patents = 24

% Expired Patents = 16.7

CIPO Patents = 5

EPO Patents = 10

Trademarks = 2

Forward Citations = 33

Loading Chart...

Loading Chart...

46 inventors (with patents filed for the assignee):

David James Owen (11 out of 11 patents)

Brian Devlin Kelly (11 out of 12 patents)

Guy Yeoman Krippner (6 out of 9 patents)

4. Peter Karellas (6 out of 6 patents)

5. Pasquale Razzino (5 out of 5 patents)

6. Scott Andrew Henderson (5 out of 5 patents)

7. Jacinth Kincaid Fairley (4 out of 4 patents)

8. Jeremy Robert Arthur Paull (4 out of 4 patents)

9. Zemin Wu (4 out of 4 patents)

10. Benjamin James Boyd (4 out of 6 patents)

11. Lisa Michelle Kaminskas (4 out of 4 patents)

12. Christopher John Hamilton Porter (4 out of 4 patents)

13. Charlotte Claire Williams (3 out of 3 patents)

14. George Holan (3 out of 25 patents)

15. Barry Ross Matthews (3 out of 11 patents)

24 patents: Sort by Forward Citations

1. 12653896 - TARGETED DENDRIMER CONJUGATES (2026-06-16),

2. 12616711 - Therapeutic dendrimer (2026-05-05),

3. 12514853 - Therapeutic dendrimer (2026-01-06),

4. 12071517 - Therapeutic dendrimer (2024-08-27),

5. 11970583 - Therapeutic dendrimer (2024-04-30),

6. 11219691 - Method of treatment or prophylaxis of infections of the eye (2022-01-11),

7. 11118016 - Therapeutic dendrimer (2021-09-14),

8. 10730999 - Dendrimer-drug conjugates (2020-08-04),

9. 10265409 - Macromolecules (2019-04-23),

10. 10149885 - Method of treatment or prophylaxis of infections of the eye (2018-12-11),

11. 9744246 - Macromolecules (2017-08-29),

12. 9585387 - PEHAM dendrimers for use in agriculture (2017-03-07),

13. 9155760 - Method of prophylaxis of bacterial vaginosis (2015-10-13),

14. 9127130 - Polylysine dendrimer contrast agent (2015-09-08),

15. 8703116 - Modified macromolecule (2014-04-22),

Starpharma Pty Limited is an Australian biotechnology company focused on the development of innovative dendrimer-based products for pharmaceutical and other applications. The company specializes in drug delivery systems, enhancing the efficacy and safety of existing therapies. Starpharma's research extends into areas such as oncology, antiviral treatments, and contraceptive technologies, leveraging its proprietary dendrimer technology to create novel solutions that address unmet medical needs globally.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

24 Patents

#1 in Abbotsford

#128 in Australia

#26,595 in the World

Abbotsford, Australia

Starpharma Pty Limited

Forward Citations = 33

46 inventors:

David James Owen (11 out of 11 patents)

Brian Devlin Kelly (11 out of 12 patents)

Guy Yeoman Krippner (6 out of 9 patents)

4. Peter Karellas (6 out of 6 patents)

5. Pasquale Razzino (5 out of 5 patents)

Please report any incorrect information to [email protected]

Loading…